Treatment with antibodies against IL-17A has been shown to inhibit disease in NOD mice (48), and Th17 cells have been shown to drive pancreatic inflammation and their transfer into NOD.scid mice induced diabetes, but only after converting to Th1 cells (49). Here, IL17A is linked to diabetes mellitus.